Last updated: April 12, 2024
Sponsor: Leiden University Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Birth Defects
Treatment
Ultrasound
Clinical Study ID
NCT05952583
CONTR
Ages 18-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- MCDA twin pregnancy
- Diagnosis of sFGR before 28+0 weeks of GA (independent of Doppler flows)
- Pregnant woman ≥ 18 years and able to consent
- Partner (who has (future) parental responsibility - if applicable) ≥ 18 years and ableto consent
- Written informed consent of both parents (if applicable) for participation in thelongitudinal follow-up until 2 years after birth)
Exclusion
Exclusion Criteria:
- The presence of lethal anomalies (one or both fetuses)
- Multiple pregnancy higher order than twins;
- TTTS/TAPS present at moment of sFGR diagnosis.
Study Design
Total Participants: 274
Treatment Group(s): 1
Primary Treatment: Ultrasound
Phase:
Study Start date:
February 17, 2023
Estimated Completion Date:
March 01, 2028
Study Description
Connect with a study center
Universitaire Ziekenhuizen Leuven
Leuven, 3000
BelgiumActive - Recruiting
Mount Sinai Hospital
Toronto, Ontario ON M5G 1X5
CanadaActive - Recruiting
Leiden University Medical Center
Leiden, Zuid-Holland 2333 ZA
NetherlandsActive - Recruiting
BCNatal
Barcelona, 08028
SpainActive - Recruiting
Karolinska University Hospital
Stockholm, 17164 Solna
SwedenSite Not Available
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.